Range Yourself

Best GLP-1 Programs for PCOS (2026)

GLP-1 telehealth programs for women with polycystic ovary syndrome — programs that consider insulin resistance and weight loss in PCOS.

GLP-1 medications can be especially effective in women with polycystic ovary syndrome (PCOS) because they directly address the insulin resistance underlying many PCOS cases. The right program understands that context.

Who this list is for

Women with PCOS seeking GLP-1 programs that consider their endocrine context.

Ranked programs

Best GLP-1 Programs for PCOS (2026) — verified May 7, 2026
ProviderAll-in monthlySemaglutideTirzepatideCompounded vs brandInsurance accepted?Last verified
$189/moFrom $169/moFrom $239/moCompoundedNoSee pricing →
$199/moFrom $179/moFrom $249/moCompoundedNoSee pricing →
$79/mo + RxBrand cost variesBrand cost variesBothYesSee pricing →
$209/moFrom $189/moFrom $259/moCompoundedNoSee pricing →
$209/moFrom $189/moFrom $259/moCompoundedNoSee pricing →
$99/mo + RxVaries by clinicianVaries by clinicianBothNoSee pricing →

Why we ranked them this way

  • PCOS is often driven by insulin resistance — GLP-1 medications improve insulin sensitivity directly, which is one reason they’re increasingly used off-label in PCOS.
  • Some women with PCOS see menstrual cycle improvement on GLP-1 even without significant weight loss. A program that follows up on cycle changes is helpful.
  • Found is included because it can prescribe metformin alongside or instead of GLP-1 — a useful option in PCOS where metformin remains first-line for many patients.

The picks in detail

Sprout Health

Best for: Balance of price and clinical support.

Watchout: Pricing changes with dose escalation — confirm long-term cost.

Pricing: $189/mo all-in (medication included)semaglutide from $169/mo, tirzepatide from $239/mo.

See Sprout Healthpricing →

TMates

Best for: Compounded GLP-1 with hands-on clinical touch.

Watchout: Confirm what the higher tiers include vs the entry tier.

Pricing: $199/mo all-in (medication included)semaglutide from $179/mo, tirzepatide from $249/mo.

See TMatespricing →

Mochi Health

Best for: Brand-name access where insurance can apply.

Watchout: Final cost depends heavily on insurance and pharmacy.

Pricing: $79/mo membership + medicationsemaglutide brand cost varies, tirzepatide brand cost varies.

See Mochi Healthpricing →

Embody

Best for: Personalized compounded blends and hands-on support.

Watchout: Custom blends warrant extra scrutiny on ingredient transparency.

Pricing: $209/mo all-in (medication included)semaglutide from $189/mo, tirzepatide from $259/mo.

See Embodypricing →

Winona

Best for: Women navigating GLP-1 alongside menopause or hormone care.

Watchout: Best fit if you also want hormone-related care; otherwise simpler GLP-1 programs may cost less.

Pricing: $209/mo all-in (medication included)semaglutide from $189/mo, tirzepatide from $259/mo.

See Winonapricing →

Found

Best for: Personalized prescribing across drug classes.

Watchout: Final medication may not be GLP-1 if clinician recommends otherwise.

Pricing: $99/mo membership + medicationsemaglutide varies by clinician, tirzepatide varies by clinician.

See Foundpricing →

Frequently asked questions

Are GLP-1s FDA-approved for PCOS?

No. GLP-1s are not FDA-approved specifically for PCOS but are commonly prescribed off-label for weight loss and insulin resistance in PCOS patients. Off-label prescribing is legal and widespread.

Will GLP-1 fix my PCOS?

GLP-1 doesn’t cure PCOS but addresses major drivers — insulin resistance, weight, and inflammation. Many women see cycle regularity improve, anovulation resolve, and androgens decrease as weight comes down.

Can I take metformin and GLP-1 together?

Yes — many PCOS patients take both. Metformin and GLP-1 work through different mechanisms and are often combined. Found, Mochi, and Sprout Health can prescribe both where clinically appropriate.

Related guides

RangeYourself is reader-supported. We may earn a commission when you click on certain links — at no extra cost to you. Editorial recommendations are made independently. Last reviewed May 7, 2026.